Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 2018. ,
Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis, Lancet, vol.358, pp.781-787, 2001. ,
Neoadjuvant chemotherapy and concurrent chemoradiation in the treatment of advanced cervical cancer, Anticancer Res, vol.21, pp.3525-3558, 2001. ,
Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix, Cochrane Database Syst Rev, p.2225, 2005. ,
, Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration (CCCMAC)
, Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis, Cochrane Database Syst Rev, p.8285, 2010.
Concurrent cisplatinbased chemotherapy plus radiotherapy for cervical cancer--a meta-analysis, Clin Oncol (R Coll Radiol), vol.14, pp.203-215, 2002. ,
Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer, Cochrane Database Syst Rev, p.10260, 2015. ,
,
, Results of surgery after concurrent chemoradiotherapy in advanced cervical cancer: comparison of extended hysterectomy and extrafascial hysterectomy, Int J Gynecol Cancer, vol.20, pp.268-75, 2010.
Surgical morbidity and oncologic results after concurrent chemoradiation therapy for advanced cervical cancer, Int J Gynaecol Obstet, vol.125, pp.111-116, 2014. ,
Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01, J Clin Oncol, vol.22, pp.872-80, 2004. ,
Details of recurrence sites after definitive radiation therapy for cervical cancer, J Gynecol Oncol, vol.27, p.16, 2016. ,
Patterns of recurrence and prognosis in locally advanced FIGO stage IB2 to IIB cervical cancer: Retrospective multicentre study from the FRANCOGYN group, Eur J Surg Oncol, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02468510
Metabolic response on post-therapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer, Int J Radiat Oncol Biol Phys, vol.83, pp.185-90, 2012. ,
Posttherapy surveillance monitoring of cervical cancer by FDG-PET, Int J Radiat Oncol Biol Phys, vol.55, pp.907-920, 2003. ,
Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma, JAMA, vol.298, pp.2289-95, 2007. ,
Roles of posttherapy 18F-FDG PET/CT in patients with advanced squamous cell carcinoma of the uterine cervix receiving concurrent chemoradiotherapy, Eur J Nucl Med Mol Imaging, vol.45, pp.1197-204, 2018. ,
18F-fluoro-2-deoxy-Dglucose positron emission tomography standard uptake value ratio as an indicator of cervical cancer chemoradiation therapeutic response, Int J Gynecol Cancer, vol.21, pp.1117-1140, 2011. ,
18 F-FDG PET/CT following chemoradiation of uterine cervix cancer provides powerful prognostic stratification independent of HPV status: a prospective cohort of 105 women with mature survival data, Eur J Nucl Med Mol Imaging, vol.42, pp.1825-1857, 2015. ,
,
, Complete metabolic response after definitive radiation therapy for cervical cancer: patterns and factors predicting for recurrence, Gynecol Oncol, vol.127, pp.303-309, 2012.
Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography-computed tomography for response evaluation in recurrent carcinoma cervix: does metabolic response predict survival?, Int J Gynecol Cancer, vol.24, pp.312-332, 2014. ,
The prognostic value of PET and PET/CT in cervical cancer, Cancer Imaging, vol.8, pp.146-55, 2008. ,
18 Fluoro-2deoxy-d-glucose-positron emission tomography and locally advanced cervical cancer, Int J Gynecol Cancer, vol.19, pp.8-12, 2009. ,
Can surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment?, Cancer, vol.118, pp.392-403, 2012. ,
Value of magnetic resonance and 18 FDG PET-CT in predicting tumor response and resectability of primary locally advanced cervical cancer after treatment with intensity-modulated arc therapy: a prospective pathology-matched study, Int J Gynecol Cancer, vol.22, pp.630-637, 2012. ,
Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium ,
, Int J Gynaecol Obstet, vol.105, pp.103-107, 2009.
,
, fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome, J Clin Oncol, vol.22, pp.2167-71, 2004.